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Abstract
Lower-extremity osteoarthritis (OA) is a prevalent musculoskeletal disease in 
elder population. The main symptom of OA is pain which leads to muscle weakness 
and physical disability. Recently, muscle weakness, function limitation, and severity 
of disease in OA are addressed to aging-related muscle attenuations. Therefore, elder 
individuals with OA are under potential sarcopenia risks. In addition, obesity, which 
exerts negative impacts on disease outcomes, has become a burden in OA population. 
Under multifactor risks of OA, it is important to identify effectiveness of multidis-
ciplinary management for such elder population to prevent sarcopenic obesity and 
maintain physical function. Previous studies have indicated that diet intervention 
(DI) using protein supplement, dietary protein, or weight loss enhances exercise 
efficacy in terms of additional muscle mass and strength gains to exercise training 
(ET) for elder individuals with high sarcopenia and frailty risks. However, it remains 
unclear whether DI in combination with ET augments any benefit for older adults 
with lower-extremity OA. This chapter aimed to review the effects of DI plus ET on 
muscle mass, strength, and physical function outcomes in older individuals with 
lower-extremity OA.
Keywords: sarcopenia, osteoarthritis, protein supplement, exercise training,  
muscle mass, function outcome
1. Introduction
Elderly population aged 65 and over is a substantially growing population which 
is estimated to exceed 16% of global population worldwide in the year of 2050 [1]. 
Elongation of life expectancy is accompanied with an increase of chronic diseases 
leading to restricted physical function and disabilities in daily life [2, 3], among 
which musculoskeletal disorder is a significant public health issue with 7.5–35.2% of 
the elder people having mild to moderate musculoskeletal conditions [3, 4] and has 
become the second cause of global burden worldwide compared with other causes 
of morbidity-mortality [5].
Among the age-related musculoskeletal disorders, osteoarthritis (OA) is one of 
the most prevalent musculoskeletal diseases from the sixth to the ninth decade of 
lifespan, especially the OA in lower extremities is closely associated with limitations 
of functional activities and participation [6]. In addition, sarcopenia, obesity, or 
in combination of both called sarcopenic obesity have great impacts on physical 
function in older adults [7, 8]. The impacts of sarcopenia on musculoskeletal system 
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are accounted to the risks of physical limitation in elder individuals, especially those 
with hip or knee OA [9, 10]. The age-related muscle dysfunction can be addressed 
to impairments in musculoskeletal system as well as neuromuscular system [11, 12]. 
With respective to the underlying mechanisms of sarcopenia in older population, 
muscle atrophy (i.e., decline in muscle size) plays a key role in muscle attenuation 
[11], especially the type II myofiber [13]. The loss of muscle mass occurs progres-
sively from middle-age by a rate of 0.47% per year in men and 0.37% per year in 
women [14]; in people aged 75 years, muscle mass is decreased at a rapid rate of 
0.64–0.70% per year in women and 0.80–0.98% per year in men and in severe 
diseases can lead to a loss of approximate 50% by the 8–9th decade of life [15]. Loss 
of skeletal muscle mass is commonly accompanied with deficits in muscle function 
such as muscle weakness, which is relevant to clinical presentation of sarcopenia as 
well as OA. Reid et al. indicated that leg lean mass is strongly associated with muscle 
strength (r = 0.78, p < 0.01) [16]. Liu et al. further indicated that low handgrip 
strength is strongly associated with decreased skeletal muscle mass in elder indi-
viduals [17]. Because of that loss of muscle strength may lead to physical difficulty 
and disability, low muscle mass has been identified as a crucial factor of functional 
limitation of physical mobility such as walk capability and chair rise [8, 17, 18].
Recently, the disease progression of knee and hip OA has been attributed to 
age-related decline in muscle mass (i.e., sarcopenia). Toda et al. reported that older 
women with knee OA experienced significantly lower leg lean mass relative to body 
weight (%) by a mean ± standard deviation of 19.2 ± 2.7%, compared with the 
healthy control (21.0 ± 2.9%; P < 0.0001) [19]; Lee et al. observed similar results 
which indicated that older adults with knee OA had a mean appendicular skeletal 
muscle mass of 15.6 kg which is significant lower than that of healthy control 
(17.3 kg, P < 0.001) [20]. Additionally, Jeon et al. reported that lower skeletal 
muscle mass independently associated with knee radiographic OA [odds ratio (OR) 
1.34; 95% confidence interval (CI) 1.04, 1.75] [21]. Therefore, older people with 
knee OA are considered at high risk of sarcopenia [22]. Grimaldi et al. observed 
muscle mass decreased in patients with hip OA in terms of 2.6–14.4% muscle atro-
phy of gluteal muscle group in the affected side compared to those in the uninvolved 
side, whereas such asymmetry in muscle volume ranged from 0.4 to 3.7% in control 
peers [23]; in addition, the muscle volume asymmetry is positively associated with 
disease progression of hip OA, indicating that patients with moderate to severe 
OA may experience greater muscle mass loss than mild-severity or asymptomatic 
patients [24]. Therefore, the OA population faces not only age-related muscle 
attenuation (i.e., sarcopenia) but also the disease-induced muscle loss.
The sarcopenia, obesity, and OA are becoming major threats to aging society 
and have been recognized as important health issues [8, 25–27]. The relationships 
among sarcopenia, obesity (i.e., sarcopenic obesity), and OA have been discussed. 
Kemmler et al. conducted an observational study to investigate the prevalence of 
sarcopenia in community-dwelled women who aged 70 years and older; the results 
indicated that elder women with lower-extremity OA exhibited a significantly 
higher rate of sarcopenia (9.1%) than nonarthritic peers (3.5%) [28]. Jin et al. 
reported that elder men and women with sarcopenic obesity showed significantly 
higher risks of exhibiting knee OA (OR = 1.92–2.43) compared with the healthy 
control groups [29]. Misra et al. conducted a longitudinal study of the risk of 
radiographic OA in relation to sarcopenic obesity; the result showed that elder 
people with sarcopenic obesity (RR = 1.91) had increased risks of exhibiting knee 
OA within a 5-year interval of follow up [30]. Therefore, preventive efforts for the 
obese elder individuals may need to focus not only on reducing sarcopenia but also 
on improving sarcopenic obesity to reduce the growing incidence and prevalence of 
knee OA.
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2. Treatments and management for sarcopenia in elderly
Sarcopenic obesity originates from a multifactorial consequence of aging and 
its related physical inactivity [31], which especially exerts negative impacts to 
obese elderly populations [32]. Several approaches for management of sarcopenic 
obesity have been recommended including pharmacological interventions, exercise 
interventions, and nutrition interventions to counteract muscle loss and physical 
declines in obese older adults [33]. According to the recommendations from the 
European Society for Clinical Nutrition and Metabolism Expert Group [34], there 
are urgent needs for elder people with a risk of sarcopenic obesity to incorporate 
nutrition intervention and muscle strengthening exercise to prevent the functional 
decline.
2.1 Protein supplement plus exercise training for sarcopenic obesity
Obesity has become epidemic burden in elderly population [25]. Sarcopenic 
obesity, a recently identified phenotype of obese elderly population, is developed 
based on an underling additive effect of sarcopenia and obesity and is referred by 
the coexistence of diminished muscle mass and increased fat mass. Sarcopenia has 
been characterized by age-related muscle degeneration [35], and obesity with an 
increased body fat exerts negative impacts on the skeletal muscle turnover and its 
homeostasis [31]. Such deteriorations of muscle mass loss originated from aging 
process result in muscle dysfunction which may further lead to physical deficits 
in frail elderly [36]. Furthermore, older adults who are identified as overweight 
or obesity have been observed suffering high risks of physical disability [37, 38]. 
Accordingly, sarcopenic obesity had been identified to be associated with more 
physical limit than either pure sarcopenia or obesity and was served as a risk to 
disability and frail life style [8, 39]. Therefore, the preservation of muscle mass and 
strength are vital for obese older adults to yield physical activities in daily life.
Aging-related attenuation of skeletal muscle mass had been addressed to a 
smaller muscle fiber size rather than loss of fiber number and characterized of type 
II myofiber phenotype dominant [13, 40]. In addition, sarcopenic muscles remain 
in a state of failing compensatory effort in an attempt to stave off muscular degen-
eration and atrophy [41]. Given the facts that myofiber hypertrophy activated by 
satellite cells is largely dependent on both net muscle protein synthesis and satellite 
cell recruitment through serious cellular processing mechanism [42, 43], and that 
both age-associated sarcopenia and obesity are associated with an over expres-
sion of myostatin which functions as a protein inhibitor negatively regulating the 
skeletal muscle growth and homeostasis with inhibiting the myoblasts proliferation 
and differentiation [44–46], it is important to identify whether resistance exercises 
exert any effect on the myofiber type-specific muscle mass loss in obese aged 
people. In such scenarios, previous trials claimed that age-related Type II myofiber 
phenotype atrophy would be improved following resistance exercise training by 
means of satellite cell proliferation and an increase in the rate of muscle contrac-
tile and mitochondrial protein synthesis, which further contributed to myofiber 
hypertrophy [40, 42, 47–51].
Progressive resistance exercise training (RET) has been used as an effective way 
of improving muscle function and increasing muscle mass by stimulating muscle 
protein synthesis in elder people [31, 49, 52, 53]. Liao et al. further indicate that 
elastic RET exerts benefits on lean mass and physical mobility in older women with 
sarcopenic obesity [54]. With respective to multidisciplinary interventions for pre-
vention of sarcopenia in elder populations, an additional protein supplements (PS) 
has also been believed to augment the effects of resistance training on muscle mass 
Muscular Atrophy
4
gain in older adults [55, 56]. For obese elderly individuals with energy restricted 
diet, PS has its effect on reduction of losing muscle mass during caloric restriction-
induced weight loss [57]. However, the effects of PS plus RET on muscle mass and 
strength gains for obese elder people remain controversy. While several studies 
identified the effects of PS on muscle mass accretion and strength gain during 
resistance training in sarcopenic or obese elderly individuals [58], some concluded 
that PS provides no additional benefit in resistance-trained obese elder individuals 
[59, 60]. Furthermore, few systemic review studies have summarized these results 
in obese elder individuals. Whether PS during RET exerts any benefit on augmenta-
tion of muscular and functional performance in obese elder people remains unclear.
Liao et al. conducted a systemic review and meta-analysis study to investigate 
effects of PS plus RET for obese elder people [61]. Main results of Liao’s study 
showed an overall effect on lean body mass (LBM) and fat mass with significant 
standardized mean differences (SMDs) of 0.58 (95% CI = 0.32, 0.84, P < 0.0001) 
and − 0.61 (95% CI = −0.93, −0.29; P = 0.0002) favoring PS plus RET, respec-
tively; similar results were observed in leg strength (SMD = 0.69, 95% CI = 0.39, 
0.98; P < 0.00001) and short physical performance battery test (SMD = 0.44, 
95% CI = 0.11, 0.78, P = 0.009). The results indicate that PS during RET inter-
vention may potentially positively contribute to changes in the body composi-
tion of overweight and obese older people. However, based on the lower body 
mass index (BMI) subgroup (mean BMI < 30 kg/m2) exhibited greater changes 
in muscle volume and handgrip strength whereas the subgroup with mean 
BMI ≥ 30 kg/m2 did not after PS, obese older individuals may be resistant to PS to 
some degree [61].
2.2  Associations of muscle mass changes with intervention effects on muscle 
strength and physical capability after protein supplement plus exercise training
Multidisciplinary approaches are recommended for elderly individuals who 
have high sarcopenia or frailty risks, including nutrient intervention alone, exercise 
training alone, or combination of both [62–66], and among which protein supple-
ment combined with exercise training (PS + ET) has been widely employed to 
augment lean mass gain, strength gain, and physical function enhancement in 
elderly individuals, irrespective of PS types and exercise protocols [65, 67–69]. 
However, whether intervention-induced changes in muscle mass contribute to 
strength gain and physical mobility improvement after PS + ET remains unclear. 
Several previous meta-analysis studies have reported that an increase in lean mass 
is accompanied by significant increases in strength gain [61, 68, 70–72] as well as 
physical mobility [68, 72] following PS + ET; however, such simultaneous increases 
in lean mass with strength [67, 73] (or physical function [61, 71]) were not observed 
by other researchers. Low muscle mass strongly predicts strength loss and mobility 
limitations in older adults [17, 74]; in addition, sarcopenia has been addressed to 
suppressed muscle protein turnover and homeostasis [75, 76]; therefore, identifica-
tion of relationship between the muscle mass changes and physical improvements in 
response to PS + ET can facilitate clinical practitioners to efficiently make optimal 
decisions and set appropriate intervention strategies for elderly patients who are 
diagnosed as sarcopenia or frailty.
Liao et al. conducted a systemic review and meta-regression study to determine 
the associations of lean mass changes with treatment effects on strength and physical 
mobility after PS + ET [77]. Main results of Liao’s study showed an overall effect on 
LBM and appendicular lean mass (ALM) with significant SMDs of 0.66 (95%CI: 
0.41–0.91, P < 0.00001) and 0.40 (95%CI: 0.15–0.66, P = 0.002) favoring PS + ET, 
respectively; similar results were observed in leg strength (SMD = 0.65, 95% CI: 
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0.39–0.90; P < 0.00001) and walking capability (SMD = 0.33, 95% CI: 0.14–0.52; 
P = 0.0006). Meta-regression analysis results of Liao’s study showed that significant 
associations were observed between changes in ALM (β = 0.08, P = 0.003) and 
SMDs of leg strength; the results further indicated that elderly individuals who 
achieved an increase in ALM of >2.5% in response to PS + ET may have obtained a 
positive effect size of leg strength. In addition, changes in ALM were significantly 
associated with effect sizes of walking capability (β = 0.17, P = 0.04). According to 
the Liao’s results, intervention-induced muscle mass gains have contributions in 
strength gain and function recovery after PS + ET, particularly the elderly who have 
sarcopenia and frailty risks.
3.  Management of muscle deficits for mild to moderate severity of 
osteoarthritis
Since OA has been recognized as a serious musculoskeletal disease [78], man-
agements of OA comprise multidisciplinary interventions including pain medica-
tions and nonpharmacological treatments for those patients who exhibit mild to 
moderate symptoms. However, surgical treatments such as total joint arthroplasty 
that could help to relief pain and improve joint function (e.g., range of motion and 
strength) [79] are commonly recommended at the end stage of OA.
Evidences regarding the effects of ET alone or PS plus ET on muscle mass, 
strength, and physical mobility have been well established in elderly populations 
with sarcopenia (Figure 1). However, whether ET alone or PS plus ET exert any 
benefit on muscle mass and function outcomes remains unclear. Based on that 
low muscle mass is closely associated with OA and elder individuals with OA have 
high sarcopenia risk [10, 28], it is urgent to generate effective strategy to manage 
this condition for the rapidly growing OA population. In addition, it is necessary 
Figure 1. 
Summary of evidences regarding effects of exercise and diet interventions on sarcopenia, sarcopenic obesity, and 
osteoarthritis. Black, green, and red arrow lines indicate exercise alone, protein supplement plus exercise, and 
diet interventions plus exercise, respectively. (+): significant intervention effect; (++): significantly additional 
effect; (?) unclear additional effect. RET, resistance exercise training; MET, multicomponent exercise training; 
PS, protein supplement; DP, dietary protein; WL, weight loss.
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to identify evidence of intervention effects on muscle mass and strength gains for 
elder people with OA.
3.1 Exercise training
Among the interventions of OA, exercise therapy is recommended as one of 
the first-line treatments [80]. Exercise exerts benefits on pain reduction, muscle 
strength, and physical function in elder individuals with OA, regardless of exercise 
types [81]. Especially, the muscle strength-based exercise training (MSE) has been 
encouraged to minimize degenerative muscular function associated with aging 
[82, 83], because of that elder individuals experience well muscular adaptations 
in terms of muscle morphological and architectural changes responding to MSE 
[84]. Therefore, MSE has been recommended for elder people with OA to augment 
muscle volume and enhance muscle hypertrophy [80].
Previous results have shown that MSE exerts benefits on muscle mass gain in 
elderly people. Churchward-Venne et al. indicated that older individuals achieved 
significantly temporal changes in whole body lean mass at 12-week and 24-week 
follow up by 0.9 ± 0.1 kg (P < 0.001) and 1.1 ± 0.2 kg (P < 0.001), respectively, 
responding to prolonged resistance-type MSE with an intensity of 60–80% 1RM 
and an intervention duration of 24 weeks [85]. In a meta-analysis, Peterson et al. 
indicated that resistance exercise exerts significant effects on increasing LBM with 
a pooled mean difference of 1.1 kg (95% CI: 0.9–1.2 kg) compared to the controls in 
older people [53].
The MSE has been served as the most promising intervention for sarcopenic 
elderly [62, 86] as well as those with OA [87–90] to increase strength and improve 
mobility. Due to that MSE enables older adults to yield increased muscle anabolic 
resistance occurring with advancing age [91, 92], resistance-type exercise training 
(RET) as well as multicomponent exercise training (MET) have been considered 
beneficial for preserving lean muscle mass in older populations, even in those with 
sarcopenia [53, 93]. In addition, muscle protein synthesis and myofiber proliferation 
can be effectively activated through MSE [94], which further contribute to skeletal 
muscle hypertrophy and muscle mass gains even in elder population [42, 43]. 
Therefore, MSE is recommend to be employed for management of OA since elder 
individuals with OA has been considered having low muscle mass [10].
However, it remains unclear that whether MSE has any effect on muscle mass 
gain and morphological changes in older individuals with lower extremities of OA. 
Studies have reported that patients with OA exhibited increased changes in the 
muscle cross-sectional area or muscle thickness after MSE [95–97], whereas other 
authors have reported conflicting conclusions that MSE exerted no beneficial effects 
on fat-free mass or muscle remodeling [98–100]. In addition, both sarcopenia and 
OA are associated with decreased muscle protein synthesis and homeostasis [75, 76], 
and exercise-induced muscular hypertrophy contributes to the increase of muscle 
strength [101]. Moreover, most of previous systematic reviews investigating the 
treatment efficacy of MSE for individuals with OA have focused on muscular 
strength and physical outcomes rather than the muscle mass or volume measures 
[87–90]. Therefore, identifying the effects of MSE on increasing muscle mass and 
volume helps clinical practitioners to develop appropriate treatment strategies for 
older people with OA.
Liao et al. conducted a systemic review and meta-analysis study to investigate 
effects of MSE for elder people with lower extremity OA [77]. Main results of sys-
temic review and meta-analyses showed MSE has effects on changes in muscle mass 
gain (SMD = 0.49, 95% CI: 0.28, 0.71; P < 0.00001), muscle thickness (SMD = 0.82, 
95% CI: 0.20, 1.43; P = 0.009), and muscle cross-sectional area (SMD = 0.80, 95% 
7Management of Sarcopenic Obesity for Older Adults with Lower-Extremity Osteoarthritis
DOI: http://dx.doi.org/10.5772/intechopen.93487
CI: 0.25, 1.35; P = 0.004) compared with nonexercise controls. Liao’s study demon-
strated that MSE exerts effects on lean mass gain as well as muscle morphological 
changes in older adults with knee or hip OA. In addition, the subgroup analysis 
results suggested that older men experienced greater MSE effects on muscle thick-
ness than did women peers and those who received MSE after arthroplasty may 
achieve greater changes in muscle volume compared to those who received preop-
erative an MSE intervention or those who did not undergo arthroplasty. According 
to the results in Liao’s meta-analysis, MSE may aid in offsetting muscle attenuation 
or prevent sarcopenia in older individuals with knee or hip OA, particularly in older 
men and in those undergoing knee or hip arthroplasty.
3.2 Protein supplement
Diet intervention such as dietary protein or protein supplementation (PS) has 
been incorporated to multidisciplinary managements for OA [102], since elder 
patients with OA have potential risks of age-related sarcopenia. In addition, alterna-
tive and complementary therapeutic approaches, such as the use of a wide array of 
nutritional and physical manipulations, are becoming popular for relieving symp-
toms of OA. Several previous studies had investigated clinical efficacy of protein 
supplementation (PS) for elder individuals with knee OA [103–106]. Colker et al. 
employed a 6-week milk PS for elder individuals with OA and the results showed 
that PS achieved significant improved changes of daily activity and the Western 
Ontario and McMaster Universities Osteoarthritis Index (WOMAC) per week 
compared with the placebo group (P < 0.001) [104]; Zenk et al. conducted a similar 
study for older adults with OA and demonstrated that compared with the placebo 
supplement, a 6-week milk PS obtained significant effects on WOMAC and reduc-
tion of medication use as well as the glucosamine-supplement group did [106]. 
Arjmandi et al. further indicated that a 3-month soy-protein supplement achieved 
greater changes in pain, physical difficulty, and medical requirement than milk PS 
did, particularly for elder men with OA [103]. Regarding other types of PS, Miller 
et al. used an alternative PS of leucine enriched herbal and indicated that WOMAC 
and pain score were significantly reduced in PS group by 45% (P < 0.05) and 
21.8% (P < 0.002), respectively, compared to the placebo group (reduced 25.4% in 
WOMAC and 21.8% in pain) [105].
3.3 Protein supplement combined with exercise training
Nutritional intervention, especially the protein supplementation (PS), can 
influence outcomes for elder individuals undergoing exercise interventions such 
as resistance-based exercise training (RET) or multicomponent exercise training 
(MET). Several systematic review studies had identified benefits of PS plus exercise 
training for elder population. For healthy elder individuals, Morton et al. reported 
that prolonged PS plus RET has effects on fat free mass, mid-thigh cross-sectional 
area, and one-repetition maximum strength by significant pooled mean differences 
of 0.30 kg (95%CI: 0.09–0.52 kg; P = 0.007), 7.2 mm2 (95%CI: 0.20–14.30 mm2; 
P = 0.04), and 2.49 kg (95%CI: 0.64–4.33 kg; P = 0.01), respectively [67]. For 
overweight or obese elder individuals, Liao et al. indicated that PS plus RET exerts 
significant effects on LBM and muscle volume with the corresponding effect 
sizes being 0.58 (95% CI: 0.32–0.84; P < 0.0001) and 1.23 (95% CI: 0.50–1.96; 
P = 0.001), respectively, irrespective of the intervention period [61]. For frail 
elderly, Liao et al. demonstrated that PS plus either RET or MET exerts significant 
effects on LBM and leg strength with the corresponding effect sizes being 0.52 
(95% CI: 0.33–0.71; P < 0.00001) and 0.37 (95% CI: 0.23–0.51; P < 0.00001), 
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respectively [68]. According to the previous established evidence regarding efficacy 
of PS plus exercise training, additional PS employed during exercise training may 
exert benefits for elder population with OA. However, most of the previous systematic 
review and meta-analysis studies investigated effects of PS plus exercise training for 
sarcopenic or frail elderly people, few studies focusing on OA population who are 
potentially with a high risk of sarcopenia. Further studies are necessary to investi-
gate treatment effects of PS plus exercise on elderly population with OA.
3.4 Weight loss plus exercise for sarcopenic obesity in osteoarthritis
Given that obesity has become a burden in OA population [25], weight loss 
(WL) should be considered as an option while setting the treatment goals and 
planning rehabilitation strategies for elder people with OA. Previous studies had 
shown that maintaining or lowering BMI to the normal range (usually within 
20.0–24.9, regardless of ethic) may reduce risks or improve symptoms of OA 
[107, 108]. Felson et al. indicated that a decrease of over 50% in odds of develop-
ing OA (odds ratio = 0.46; P = 0.02) occurred in older women along with a 2-unit 
decrease in BMI or a 5.1-kg reduction in weight over a 10-year period, especially 
for those who had a baseline BMI > 25 kg/m2 (odds ratio = 0.41; P = 0.02) [108]. 
Coggon et al. concluded similar results that proportion of knee OA patients can 
be reduced from 10.9 to 57.1% while overweight and obese populations reduced 
their weight by 2–5 kg or until reaching the normal-range BMI [107]. Weight loss is 
also efficacious in relieving symptoms of knee OA, most importantly alleviating the 
pain. Riddle et al. observed a significant dose-response relationship (P < 0.003) 
exists between percentage changes in body weight and the corresponding changes 
in WOMAC pain, as well as WOMAC physical function; Riddle further indicated 
that weight changes (gain or loss) of ≥10% potentially leads to clinical important 
changes in pain and function for older individuals with OA [109]. Messier et al. 
also identified a dose response to WL for pain (P = 0.01), 6-minute walk distance 
(P < 0.0001), and function (P = 0.0006) [110]. Accordingly, WL should be 
incorporated to the management for elder individuals with OA, especially those 
who are overweight or obese.
An WL intervention may exert negative impacts on lean mass since obesity 
often masks the age-associated loss of muscle mass. Recently, WL in combination 
with exercise has been recommended as the optimal approach to managing obese 
patients with OA. Several previous trials had targeted weight management for 
obese older adults with OA including the Intensive Diet and Exercise for Arthritis 
Trial [111], the Arthritis, Diet and Activity Promotion Trial [112], and the Physical 
Activity, Inflammation, and Body Composition Trial [113]. These registered clinical 
trials employed weight-loss protocols which targeted 5–10% reduction of body 
weight over 6–18 months and incorporated partial meal replacements, nutrition 
class, and behavior therapy for diet habit changes and lifestyle modifications. 
Results from such previous trials showed that exercise training in combination with 
a weight-loss program in obese adults with knee OA achieved significantly greater 
changes in pain and function compared to the control groups. In addition, several 
systemic reviews regarding WL with or without exercise for elder OA populations 
also provide evidences for treatment efficacy on pain relief and function recovery 
[114–117]. However, the effects of WL plus exercise on lean mass remain incon-
sistency among the results of previous trials and few systemic review and meta-
analysis studies focused on the treatment efficacy on muscle mass outcome in obese 
elder individuals with OA who received WL plus exercise. Future studies should 
be warranted to investigate effects of WL plus exercise on muscle mass in order to 
prevent sarcopenia in such elder population with OA.
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Liao et al. conducted a systemic review and meta-analysis study to investigate 
effects of diet intervention plus ET for elder people with mild to moderate OA 
[118]. Among the included trials in Liao’s study, all of the included trials which 
reported muscle mass outcomes conducted a WL plus ET intervention for obese 
elder patients with knee OA [118] and the results showed that during an overall 
follow-up duration, the WL plus ET group achieved significant effects on muscle 
mass gains (SMD = 0.61; 95%CI: 0.30–0.91, P = 0.0001) compared to the control 
groups, regardless of methodological design. The results indicated that WL 
plus ET exhibited significant effects on muscle mass for obese older individuals 
with OA.
4.  Management of muscle dysfunction after total joint replacement for 
patients with end-stage osteoarthritis
4.1  Postoperative rehabilitation for muscle recovery after total joint 
replacement
Total joint replacement has been recommended for patients with end-stage of 
OA who experience poor response to pharmacological medication or conventional 
therapy [119–121]. Total knee replacement (TKR) as well as total hip replacement 
(THR) has profound benefits for pain relief, which is the main determinant of 
functional recovery following surgery.
Enhanced recovery programs after a TKR or THR surgery, which require a 
multidisciplinary team of dedicated professionals, have been well-established 
[122]. Among the perioperative interventions producing better surgery outcome, 
rehabilitation plays an important role in physical reconditioning and functional 
recovery [123]. As mentioned in the Section 2.1, muscle strengthening exercise 
(MSE) exerts benefits on muscle mass and strength gains in elder people with OA, 
and an MSE has been effectively employed following TKR or THR surgery as well to 
improve postoperative muscle and joint function [124]. However, it remains unclear 
that whether MSE exerts any effect on muscle mass after total joint replacement. It 
is important to identify the effects of MSE on muscle mass outcome following total 
joint replacement since patient who were undergoing TKR or THR may experience 
acute sarcopenia immediately after surgery [125, 126]. Due to that sarcopenia may 
have impacts on function outcome after TKR or THR, further studies should be 
conducted to warrant effective interventions for preserve muscle mass for elderly 
population with OA who recently underwent total joint replacement.
Liao et al. conducted a randomized control trial to investigate effects of post-
TKR MSE for elder women with OA [127]. Liao’s study demonstrated that an 
intervention of 12-week elastic RET following TKR surgery exerted benefits for 
muscle mass gain and physical recovery among elderly women with KOA. The 
results of this study suggest that elastic RET should be incorporated to post-TKR 
rehabilitation for patients with KOA to achieve well postoperative outcomes, espe-
cially muscle mass gains and physical mobility improvements. Liao further stated 
that the elastic RET is relatively safe and easily performed at home. The elastic RET 
protocol used in Liao’s study will help clinical practitioners and physiotherapists 
and to establish prompt treatment strategies for elderly people with KOA, especially 
those who have undergone a recent TKR and are considered to have high sarcopenia 
risk. The findings of this study indicated post-TKR elastic RET exerted benefits 
on muscle mass and function and can potentially assist clinician decision-making 




4.2 Protein supplement plus exercise training after surgery
The previous observational study has indicated that low protein intake occur-
ring in patients with OA may place themselves at high risks of sarcopenia [128]. 
Therefore, perioperative interventions including protein supplement may prevent 
elder patients from suffering acute sarcopenia and poor surgical outcome at 
early stage after total joint replacement (i.e., TKR or THR) [129–131]. Alito et al. 
employed 5-day protein-contained (23%) supplements (PS) before surgery for 
patients who were undergoing THR and the results demonstrated that comparing 
with the non-supplement control group, the PS group experienced significantly a 
lower level of C-reactive protein (mean 80.6 vs. 66.5 mg/L, P < 0.01) and a shorter 
length of hospital stay (median 6 vs. 3 days, P < 0.01) after THR [129]. Yang et al. 
used high-dose PS on the day before and after THR surgery and the results showed 
that, comparing to the standard-care group, the PS group had less proportion of 
patients who required an intravenous albumin (45.1% vs. 26.8%, P = 0.023) and 
experienced a shorter length of hospital stay (mean 5.1 vs. 3.9 days, P < 0.001) 
[130]. Bai et al. used an oral ingestion of hydrolyzed PS for 5 postoperative days 
after TKR and the results indicated that PS enhanced postoperative nutrition status 
in terms of greater changes in blood prealbumin (P < 0.03) compared to the regular-
nutrition group [131]. The previous results had indicated that diet interventions, 
especially the PS, before or after total joint replacement can enhance postoperative 
nutrient status and shorten length of acute inpatient stay which further prevent 
elder patients from experiencing acute sarcopenia.
On the basis that either perioperative diet interventions or early rehabilitation 
programs exerts benefits on surgical outcome, combination of both may provide 
additional effects on function recovery after TKR or THR. The evidences regarding 
effects of PS plus exercise for healthy, sarcopenic, and frail elder populations 
have been well established by previous systemic review and meta-analysis studies 
[61, 68, 132]. However, the elder population with OA as well as those who under-
went total joint replacement are less targeted by previous systemic reviews investi-
gating efficacy of PS plus exercise. Future studies are necessary to be warranted in 
order to identify whether PS plus exercise following TKR or THR exerts any effect 
on postoperative function outcomes.
Liao et al. conducted a systemic review and meta-analysis study to investigate 
effects of diet intervention plus ET for elder people with OA [118]. Among the 
included trials in Liao’s study, all of the included trials which reported muscle mass 
outcomes conducted a PS plus ET intervention for older patients who recently 
received a TKR or THR [118] and the results showed that during an overall follow-
up duration, the PS plus ET group achieved significant effects on muscle mass gains 
(SMD = 0.81; 95%CI: 0.45–1.17, P < 0.0001) compared to the ET control groups, 
regardless of PS type. The results indicated that PS plus ET exhibited significant 
effects on muscle mass for older individuals with OA, especially for those who 
recently received a total joint arthroplasty.
5. Conclusions
This review provides evidence that DI incorporated with ET is effective for 
promoting gains in muscle mass and strength and enhancing performance in 
physical mobility for the elder adults with lower-extremity OA, compared to 
placebo, DI-alone or ET-alone controls. In addition, muscle mass gains have effects 
on strength gain and global function recovery. Furthermore, the results of this 
study showed that PS plus ET appears to be the optimal treatment strategy for 
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those who were undergoing total joint replacement whereas WL plus ET is most 
preferred for those who experienced mild to moderate severity of OA disease. 
Therefore, we concluded that DI additional to ET may have extra effects to prevent 
or offset muscle loss and function decline for elder individuals with OA who have 
high sarcopenia risks.
6. Implications for clinical practice
This review adds current evidences of interdisciplinary approach practices 
which comprise effective nutrient and exercise intervention strategies for KOA 
populations who have potential risks of sarcopenic obesity. This review also pro-
vides references for clinical practitioners to develop efficient and effective interven-
tions for such population to prevent sarcopenic obesity.
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